HomeMBX • NASDAQ
add
MBX Biosciences Inc
Previous close
$8.64
Day range
$8.65 - $9.35
Year range
$4.81 - $26.19
Market cap
300.49M USD
Avg Volume
316.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.61M | 86.27% |
Net income | -15.59M | -76.25% |
Net profit margin | — | — |
Earnings per share | -0.47 | — |
EBITDA | -18.55M | -86.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 262.15M | 224.94% |
Total assets | 268.54M | 219.00% |
Total liabilities | 11.09M | 158.52% |
Total equity | 257.44M | — |
Shares outstanding | 33.42M | — |
Price to book | 1.12 | — |
Return on assets | -16.89% | — |
Return on capital | -17.58% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.59M | -76.25% |
Cash from operations | -16.04M | -43.88% |
Cash from investing | -67.34M | -132.59% |
Cash from financing | -132.00K | -794.74% |
Net change in cash | -83.51M | -108.36% |
Free cash flow | -11.08M | — |
About
Founded
2018
Headquarters
Website
Employees
43
